Adare Honored with 2025 Outsourced Pharma CDMO Leadership Award

We are proud to announce that Adare has been recognized as a winner of the 2025 Outsourced Pharma CDMO Leadership Awards in the Small Molecule Dosage Form – Global category.

This prestigious award highlights the top contract development and manufacturing organizations (CDMOs) across both global and regional markets, based on direct feedback from pharmaceutical and biotech companies.

Being named a winner in this category is a testament to our unwavering commitment to innovation, quality, and reliability in pharmaceutical development. It reflects the dedication of our teams, the strength of our partnerships, and our shared mission to bring life-changing therapies to patients worldwide.

We thank our clients and partners for their continued trust, and we remain focused on driving excellence in everything we do.